Cite

HARVARD Citation

    Munir, T. et al. (2022). Obinutuzumab as consolidation after chemo‐immunotherapy: Results of the UK National Cancer Research Institute phase II/III GALACTIC trial. British journal of haematology. pp. 707-719. [Online]. 
  
Back to record